BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Endocrine gland cancer AND ABL2, ARG, 27, ENSG00000143322, P42684, ABLL, RP11-177A2_3 AND Treatment
29097 results:

  • 1. Overweight as a biomarker for concomitant thyroid cancer in patients with Graves' disease.
    Park J; An S; Bae JS; Kim JS; Kim K
    Front Endocrinol (Lausanne); 2024; 15():1382124. PubMed ID: 38711981
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Physical function as a predictor of chemotherapy-induced peripheral neuropathy in patients with pancreatic cancer.
    Lin KY; Chen PS; Lin CF
    BMC Gastroenterol; 2024 May; 24(1):154. PubMed ID: 38711006
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Active surveillance is a feasible and safe strategy in selected patients with papillary thyroid cancer and suspicious cervical lymph nodes detected after thyroidectomy.
    Solórzano M; Lustig N; Mosso L; Espinoza M; Santana R; Gonzalez H; Montero PH; Cruz F; Solar A; Domínguez JM
    Arch Endocrinol Metab; 2024 May; 68():e230146. PubMed ID: 38709151
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. The prophylactic antiemetic therapies in management of differentiated thyroid cancer patients with radioactive iodine therapy: a single-center, non-randomized clinical trial.
    Li X; Cao J; Wang W; Zhu X; Sun Y; Song L; Zhang W; Han Y
    Front Endocrinol (Lausanne); 2024; 15():1310223. PubMed ID: 38706697
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Common hepatic artery lymph node metastasis in pancreatic ductal adenocarcinoma: an analysis of actual survival.
    Kuo S; Ventin M; Sato H; Harrison JM; Okuda Y; Qadan M; Ferrone CR; Lillemoe KD; Fernandez-Del Castillo C
    J Gastrointest Surg; 2024 May; 28(5):672-678. PubMed ID: 38704205
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Pituitary abscess: a descriptive analysis of a series of 19 patients-a multi-center experience.
    Xue Q; Shi X; Fu X; Yin Y; Zhou H; Liu S; Sun Q; Meng J; Bian L; Tan H; He H
    Eur J Med Res; 2024 May; 29(1):262. PubMed ID: 38698484
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Our experience with robotic-assisted thymic surgery.
    Podhráský M; Tvrdoň J; Schützner J
    Rozhl Chir; 2024; 103(2):40-47. PubMed ID: 38697812
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Impact of Bevacizumab on Clinical Outcomes in Patients With Platinum-resistant Relapsed Ovarian cancer.
    Seol A; Kim SI; Yoon HY; Lee M; Kim HS; Chung HH; Park NH; Song YS
    In Vivo; 2024; 38(3):1338-1350. PubMed ID: 38688599
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Efficacy and safety of neoadjuvant therapy in gastroenteropancreatic neuroendocrine neoplasms: A systematic review and meta-analysis.
    Yan Y; Wu D; Wang W; Lv Y; Yang L; Liu Y; Dong P; Yu X
    J Cancer Res Ther; 2024 Apr; 20(2):633-641. PubMed ID: 38687934
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. The clinical value of iodine-125 seed implantation in the treatment of iodine-refractory differentiated thyroid carcinoma.
    Wan Q; Tan L; Tang X; Wang W; Su Y; Wu Z; Ke M; Chen Z
    Front Endocrinol (Lausanne); 2024; 15():1327766. PubMed ID: 38686207
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Targeting KRAS in pancreatic cancer.
    Stickler S; Rath B; Hamilton G
    Oncol Res; 2024; 32(5):799-805. PubMed ID: 38686056
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Glucagon-like peptide 1 receptor agonist use and risk of thyroid cancer: Scandinavian cohort study.
    Pasternak B; Wintzell V; Hviid A; Eliasson B; Gudbjörnsdottir S; Jonasson C; Hveem K; Svanström H; Melbye M; Ueda P
    BMJ; 2024 Apr; 385():e078225. PubMed ID: 38683947
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Biological functions of LncRNA SNHG14 in the development of thyroid cancer cells via targeting miR-206.
    Sang Y; Min R; Huang T; Zhang J
    Cell Mol Biol (Noisy-le-grand); 2024 Apr; 70(4):77-84. PubMed ID: 38678623
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Comparison of endoscopic thyroidectomy via the oral vestibule approach and the areola approach for papillary thyroid carcinoma.
    Liu Y; Lin F; Yan W; Lin E; Kuang P; Hong X; Lu Y; Wu G; Li L
    BMC Surg; 2024 Apr; 24(1):127. PubMed ID: 38678205
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Promising Approaches in Plant-Based Therapies for Thyroid cancer: An Overview of In Vitro, In Vivo, and Clinical Trial Studies.
    Kaczmarzyk I; Nowak-Perlak M; Woźniak M
    Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38674046
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Effects of Resveratrol on In Vivo Ovarian cancer Cells Implanted on the Chorioallantoic Membrane (CAM) of a Chicken Embryo Model.
    Chitcholtan K; Singh M; Tino A; Garrill A; Sykes P
    Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673959
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. High-Grade Serous Ovarian cancer during Pregnancy: From Diagnosis to treatment.
    Vivod G; Merlo S; Kovacevic N
    Curr Oncol; 2024 Apr; 31(4):1920-1935. PubMed ID: 38668047
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Persistent hypercalcaemia associated with two pathogenic variants in the
    Leszczyńska D; Szatko A; Latocha J; Kochman M; Duchnowska M; Wójcicka A; Misiorowski W; Zgliczyníski W; Glinicki P
    Front Endocrinol (Lausanne); 2024; 15():1355916. PubMed ID: 38665259
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Identification and validation of an anoikis-related genes signature for prognostic implication in papillary thyroid cancer.
    Zhao R; Lu Y; Wan Z; Qiao P; Yang L; Zhang Y; Huang S; Chen X
    Aging (Albany NY); 2024 Apr; 16(8):7405-7425. PubMed ID: 38663918
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Exceptional lymph node recurrence of an unusual ovarian tumor 16 years later: a case report.
    Sakhri S; Slimane M; Bouaziz H; Khessairi N; Boujelbene N; Ben Dhiab T
    J Med Case Rep; 2024 Apr; 18(1):217. PubMed ID: 38654310
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 1455.